Last update 01 Nov 2024

HS-10380

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
5-HT1A receptor x D2 receptor x D3 receptor
Mechanism
5-HT1A receptor partial agonists(Serotonin 1a (5-HT1a) receptor partial agonists), D2 receptor agonists(Dopamine D2 receptor agonists), D3 receptor agonists(Dopamine D3 receptor agonists)
Therapeutic Areas
Other DiseasesNervous System Diseases
Active Indication
SchizophreniaMania
Inactive Indication-
Originator Organization
Jiangsu Hansoh Pharmaceutical Co. Ltd.Jiangsu Hansoh Pharmaceutical Co. Ltd.
Active Organization
Jiangsu Hansoh Pharmaceutical Co. Ltd.Jiangsu Hansoh Pharmaceutical Co. Ltd.Shanghai Hansoh Biomedical Co. Ltd.Shanghai Hansoh Biomedical Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

7
Clinical Trials associated with HS-10380
CTR20241250 / RecruitingPhase 2
在中国成年急性期精神分裂症患者中评估HS-10380有效性和安全性的随机、双盲、阳性药和安慰剂对照的Ⅱb期临床研究
[Translation] A randomized, double-blind, active- and placebo-controlled Phase IIb clinical study to evaluate the efficacy and safety of HS-10380 in Chinese adult patients with acute schizophrenia
CTR20233666 / RecruitingPhase 1
食物对HS-10380药代动力学影响的研究
[Translation] Study on the effect of food on the pharmacokinetics of HS-10380
ChiCTR2300078048 / SuspendedPhase 1IIT
Study on the Effect of Food on the Pharmacokinetics of HS-10380
100 Clinical Results associated with HS-10380
Login to view more data
100 Translational Medicine associated with HS-10380
Login to view more data
100 Patents (Medical) associated with HS-10380
Login to view more data
100 Deals associated with HS-10380
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SchizophreniaPhase 2-
Jiangsu Hansoh Pharmaceutical Co. Ltd.Jiangsu Hansoh Pharmaceutical Co. Ltd.
30 Jul 2023
ManiaIND Approval
CN
Shanghai Hansoh Biomedical Co. Ltd.Shanghai Hansoh Biomedical Co. Ltd.
23 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free